Medtronic Initiates Restructuring Program To Save Up To $475M Annually
The medtech giant will simplify its organizational structure, consolidate operations and give more autonomy to its individual operating units.
You may also be interested in...
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.
Medtronic will launch its next-generation MiniMed 780G insulin pump while continuing to develop complementary technologies to close the competitive gap with its rivals in the diabetes market.
The company is running a pilot program to allow glioblastoma patients who use Novocure’s Optune Tumor Treating Fields device to download data from the device at home.